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In this work, we have studied in detail the binding of two a-fucosylamide-based mimics of LewisX to
DC-SIGN ECD (ECD = extracellular domain) using STD NMR and docking. We have concluded that
the binding mode occurs mainly through the fucose moiety, in the same way as LewisX. Similarly to
other mimics containing mannose or fucose previously studied, we have shown that both compounds
bind to DC-SIGN ECD in a multimodal fashion. In this case, the main contact is the interaction of two
hydroxyl groups one equatorial and the other one axial (O3 and O4) of the fucose with the Ca2+ as
LewisX and similarly to mannose-containing mimics (in this case the interacting groups are both in the
equatorial position). Finally, we have measured the KD of one mimic that was 0.4 mM. Competitive
STD NMR experiments indicate that the aromatic moiety provides additional binding contacts that
increase the afﬁnity.
Introduction
DC-SIGN (Dendritic Cell-Speciﬁc ICAM-3 Grabbing Non-
integrin) also named CD209, is a C-type lectin present mainly
on the surface of immature dendritic cells.1 This protein shows
a short intracellular domain, a transmembrane domain, and an
extracellular region containing a neck ending in a Carbohydrate
Recognition Domain (CRD) at the C-terminus. This CRD is
responsible for the interaction with highly glycosylated structures
present at the surface of several pathogens such as viruses (HIV,
SIV, Hepatitis C), bacteria, yeasts, and parasites.2 DC-SIGN
plays a key role in the infection processes of some of these
pathogens, which are recognized by interactions of the lectin with
carbohydrate structures from pathogens’ glycoproteins (gp120,
GP1, etc.).1,2
Thus, the development of small-molecule mimics of oligosac-
charides capable of inhibiting sugar-binding by this lectin is
attracting the attention as a way to develop drugs with good
stability and synthetic availability.3,4
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Natural ligands of DC-SIGN consist of mannose oligosac-
charides such as high mannose, or fucose-containing Lewis-type
determinants. In all cases, the binding occurs in a Ca2+ dependent
manner.5–7 Many experimental and modelling studies from dif-
ferent groups have demonstrated that the Lewis oligosaccharides
are rigid and compact structures with the fucose ring stacked
on top of the galactose residue.8 Moreover, the conformation of
LewisX carbohydrate determinants 1 (Fig. 1) bound to antibodies
was found to be extremely similar to that observed for the free
oligosaccharides. Thus, the recognition and binding of the LewisX
carbohydrates by their protein partners does not induce signiﬁcant
conformational changes.8
Fig. 1 Structure of LewisX(OMe), 1 and ﬁrst fucose-based mimic 2.
Previous studies established thata-fucosylamides are functional
mimics of enzymatically and chemically labile a-fucosides. Some
of us described the ﬁrst fucose-based unnatural ligand of DC-
SIGN 2 (Fig. 1),9 an interesting candidate to prepare improved
compounds or multivalent systems able to block the lectin with
high afﬁnity. Indeed, this ligand was found to be a better inhibitor
for DC-SIGN than the natural LewisX.9
This journal is © The Royal Society of Chemistry 2011 Org. Biomol. Chem., 2011, 9, 7705–7712 | 7705
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As an improvement of this glycomimetic compound 2, a library
of potential new mimetics have been prepared and evaluated as
inhibitors of DC-SIGN using biosensors.10 From this library, we
have selected two of the most active ligands, 3 and 4, containing
the same a-fucosylamide anchor used in 2, and an aromatic ring
to take advantage of potential CH–p interactions.11,12 We have
performed a full analysis of their interaction with the ECD of
DC-SIGN (Fig. 2),10 by NMR and computational techniques.
Ligand binding was analysed mainly by Saturation Transfer
Difference (STD)NMR spectroscopy, one of the most widespread
NMR methods, together with transfer NOE, to characterize
binding interactions between small ligands and macromolecular
receptors.13
Fig. 2 New fucose-based glycomimetic ligands containing an
a-fucosylamide anchor and an aromatic ring.
In addition, we have investigated the existence of multiple
binding modes using the CORCEMA-ST protocol (Complete
Relaxation and Conformational Exchange Matrix), a useful tool
for analysing the STD data and obtaining STD-based epitope
mapping on a quantitative basis.14,15
Results and discussion
The two mimics studied, 3 and 4 (Fig. 2), belong to a library of
fucosylamides compounds, designed as potential ligands for DC-
SIGN ECD.10 They have been chosen based on previous studies
and binding afﬁnity data obtained by SPR. They differ only in the
aromatic ring and they have been selected in order to evaluate the
inﬂuence of the aromatic moiety on afﬁnity.
Structural analysis of the free ligands 3 and 4
Both compounds are rather ﬂexible systems and the a-glycosyl
amides are poorly parameterized in available force ﬁelds for
molecular mechanics calculations. However, coupling constant
analysis and NOESY spectra allowed us to restrict the range of
possible conformations of the ligands in solution (see ESI† and
Fig. 3). This conformational analysis reproduced the experimental
data observed for free ligands 3 and 4. Due to the structural
and spectral similarities between both ligands, the focus of the
computational study in the free-state is just on one of the
compounds (mimic 3).
In a ﬁrst step, a conformational analysis of the central ring was
performed based onNMRdata. Experimental coupling constants
of mimic 3, determined by homonuclear decoupling, revealed a
single conformation of the cis-b-aminoacid (C ring), in which the
carbonyl group is in the equatorial position, and the amino group
Fig. 3 Representative conformer of 3 showing key NOE cross peaks.
in the axial one (see ESI†), as already determined in previous
studies for the parent compound (2).9
Monte Carlo Multiple Minimum (MCMM)16 conformational
searches and mixed mode MC/SD dynamics simulations17 were
performed using Macromodel-AMBER*,18–20 MM3*21,22 and
OPLS_200523 force ﬁelds combined with the GB/SA water
solvation model.24 In the case of AMBER*, while all conformers
presented the chair conformation of the C ring, in agreement with
the experimental J-coupling constant, only one structure showed
interatomic distances consistent with the experimental NOE
results. Conformers arising from MM3* multiple minimization,
showed interatomic distances in agreement with NOE data,
but also showed a number of low energy solutions inconsistent
with the C ring chair conformation determined from coupling
constants. Although a more realistic ensemble could be obtained
disallowing ring opening, the best agreement was obtained using
the OPLS_2005 force ﬁeld. Both, multiple minimization18 and
dynamics gave rise to conformers whose conformation of the C
ring and interprotonic distances ﬁt well with the experimental ones
(Table 1).
Due to the similar structures of compounds 3 and 4, we assumed
the same reasoning for compound 4 and therefore a comparable
free conformation was accepted (see NOESY spectra in ESI†).
Conformational analysis of the bound ligands
Structural analysis of the ligand–receptor complexes. In the
presence of the lectin, the sign ofNOEcross peaks become inverted
indicating ligand–protein binding at a favourable rate (Fig. 4).
Furthermore, the key inter residue NOE signals described above
(Table 1) are stronger in the presence of the receptor (trNOE).
In general, with the exception of the peaks’ intensities and sign,
no major differences appeared between the NOE ﬁngerprints
for free and bound ligand 3 (Fig. 4). This indicates that the
lectin recognizes the conformation of the oligosaccharide that
corresponds to the main conformation existing in solution.25 In
addition, trROESY experiments were also recorded in order to
identify false trNOEs due to spin-diffusion effects26,27 and the
spectra conﬁrmed the trNOE peaks.
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Table 1 Calculated and experimental inter-proton distances (A˚) for mimic 3 in comparison with key NOE contacts
MC/SD Distance (A˚)a MC+MC/SD Distance (A˚)b
Proton pair MM3* AMBER* OPLS 2005 MM3* AMBER* OPLS 2005
Experimental
Distances (A˚)c
NOE
intensity
H-1 F/H-1 C 4.5 4.5 4.3 4.4 4.5 4.3 3.8 —
H-5 F/H-5 C 3.8 4.5 3.1 3.1 5.3 2.9 3.4 weak
H-5 F/H-2 Ph 6.1 5.3 6.7 5.6 4.7 6.5 — —
H-5 F/H-6 Ph 3.8 4.0 4.5 4.1 3.7 4.2 3.9 very weak
H-5 F/H-2 Ph 3.9 4.2 4.5 4.0 3.8 4.2 3.8 weak
Me F/H-2 Ph 4.4 5.6 4.1 4.1 5.7 3.4 3.9 medium
Me F/H-5 Ph 5.2 5.7 5.7 4.7 5.1 5.4 — very weak
Me F/H-6 Ph 4.3 5.5 4.2 4.2 5.8 3.6 4.0 weak
a Distances evaluated from <r-6>-1/6 monitored during the simulation. b Distances obtained from MD minimized snapshots, calculated as average of
the <r-6> of the individual conformations accessible in the ﬁrst 3 kcal mol-1. c Distances derived using the isolated spin-pair approximation (ISPA) by
comparing relative NOE intensities.
Fig. 4 Expansions of NOESY experiments at 500 ms of mimic 3, free
(left), and in the presence of 19 mM of DC-SIGN ECD (right), showing
some key NOE peaks. The Me–H-4 Ph NOE peak was also observable in
the free state (left), but close to the noise level (not shown).
A working model for the structure of DC-SIGN in complex
with mimic 3 was obtained by docking studies starting from the
PDB structure of humanDC-SIGN (pdb entry 1SL5).7 The X-ray
crystal structure was modiﬁed removing all crystallographic water
molecules except W13 and W36, since previous studies identiﬁed
two hydrophilic areas with favourable energy occupied by these
water molecules.28 The role of water molecules in the binding
between lectins and glycosylated ligands is a matter of current
interest because of their potential contribution to the ligand–
receptor binding.29,30
One of the starting ligand structures used for docking was the
global minimum from the multiple minimization of the ligand
discussed above. A rigid docking (see ESI†) was performed by
superimposing the fucose ring of mimic 3 with the fucose residue
ofLewisX as it is in the crystallographic structure (pdb entry 1SL5).
A semi-ﬂexible docking was performed by Glide (Grid-Based
LigandDockingwithEnergetics),31–34 while ligand conformational
ﬂexibility is handled by a conformational search.
All docked poses generated appeared to maintain the inter-
actions between the Ca2+ atom and two hydroxyl groups of the
fucose residue, predominantly groups OH-3 and OH-4. Only one
of the poses was able to explain the key interresidue NOE signals
experimentally observed (Fig. 3 and 4). Nevertheless, in this case
QM-docking yielded worse results than standard docking. The
structure in Fig. 5 has been selected from the previous results
using the experimental data as a ﬁlter.
Fig. 5 Best docking pose of mimic 3 in the binding pocket of DC-SIGN
as selected by semi-ﬂexible docking taking into account the experimental
evidence (Schrodinger, Inc.).
The STD experiments conﬁrm the theoretical data, both
compounds interact mostly through the fucose residue that binds
a Ca2+ atom, an additional contribution from aromatic signals is
detected for 3 and 4, and other weaker signals from the cyclohexyl
ring are also observed (Fig. 6). This is consistent with the hairpin-
like shape of the molecules in which the central ring is far from
the surface of the protein, the aromatic ring is interacting with
Phe-313 while the fucose is interacting with Ca2+ by two adjacent
hydroxyl groups (see Fig. 5 and 6).
Based on experimental evidence, among all docked poses
obtained, we chose only one from the semi-ﬂexible docking (Fig.
5). This complex was our starting point to apply the CORCEMA-
ST protocol in order to predict the STD intensities based on the
topology of themolecularmodels.14,15 From the docked posewhich
presents the coordination between the Ca2+ atom and hydroxyl
This journal is © The Royal Society of Chemistry 2011 Org. Biomol. Chem., 2011, 9, 7705–7712 | 7707
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Fig. 6 STD and reference spectra of a) mimic 3 (1 mM) and b) mimic 4
(1 mM) in the presence of DC-SIGN ECD (19 mM) at 10 ◦C, 500 MHz.
Protons belonging to phenol ring (Ph), pyridine ring (Py), fucose (F, Me)
and to cyclohexyl ring (C) are labelled.
groups 3 and 4 of fucose (model O3–O4), we built three other
models of interaction and minimized them using MacroModel
(models O4–O3, O2–O3 and O3–O2, for nomenclature see ESI†).
In CORCEMA-ST the simpliﬁed expression for the observable
magnetization I(t) in a STD experiment is given by eqn (1)14,15
I(t) = I0 + [1 - exp{-Dt}]D-1Q (1)
We have calculated STD intensities of different protons in
the ligand of the four complexes and compared them with the
experimental values (ESI†).35 None of the individual solutions
satisﬁed all the experimental data. However, combinations of
several associationmodes could be feasible assuming the existence
of multiple binding modes. Nevertheless, in terms of qualitative
ranking of STD intensities within ligand protons, a main contri-
bution of the structure O3–O4 is strongly suggested.
STD NMR epitope mapping. We performed STD NMR
experiments, at different saturation times of LewisX 1 and mimics
3 and 4, in the presence of 19 mMofDC-SIGN (ECD)which exists
in solution as a tetramer.36
For all three compounds, fucose protons H-1 F, H-2 F, H-3
F receive the largest amount of saturation indicating a common
binding mode in which these protons are very close to the protein.
In all cases F-1 receives the major amount of magnetization.
Protons H-4 F, H-5 F and the methyl group are also involved
in binding but show smaller STD. This conﬁrms that the inter-
action with the lectin occurs mainly through the fucose residue7
consistent with the expected binding mode.9 On the other hand,
for mimics 3 and 4, the observation of STD signals belonging to
protonsH-1 andH-2 of the C ring, indicates that the fucosylamide
anchor makes close contacts with the protein. In addition, signals
corresponding to the aromatic moiety were evident in the STD
spectra of the mimics, indicating a further interaction of this ring
with the ECD of DC-SIGN (Fig. 6).
We characterized the binding epitope using relative STD
intensities, as introduced by Mayer and Meyer37 (Fig. 7) and the
analysis of initial growth, proposed by Mayer and James.38 Using
this approach the slope corresponds to the STD intensity in the
absence of T1 bias. Thus, the experimental curves were ﬁtted to
an exponential function described by the equation: STD (tsat) =
STDmax(1 - exp(-ksattsat)) which allows us to calculate STD at zero
saturation time (STD0) by the resulting parameters STDmax and
ksat.38 These STD0 were then used to calculate the binding epitope
independently of T1 and rebinding effects.39
The results demonstrate that the fucose based ligands bind the
protein mimicking the recognition of known natural ligands as
the LewisX antigen, this is, through the fucose residue, while the
aromatic rings in the mimics provide additional contact points
with DC-SIGN (Fig. 6 and 7).
KD determination by STD NMR
In order to obtain the dissociation constant (KD) of 3 we used
a protocol based on STD NMR, recently developed in our
group.39 This method allows direct measurements of receptor–
ligand dissociation constants (KD) from single-ligand titration
Fig. 7 Relative values of STD ampliﬁcation factors for a) mimic 3 b) mimic 4 c) LewisX 1. Ligand concentration 1 mM, DC-SIGN ECD 19 mM, in
500 mL buffer D2O (150 mM NaCl, 4 mM CaCl2, 25 mM d-Tris, pD 8). The ratio of intensities ISTD/I 0 was normalized using the largest STD effect
(anomeric proton H-1 of the Fucose residue (100%) as a reference).
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experiments, by constructing the binding isotherms using the
initial growth rates of the STD ampliﬁcation factors (STD-AF0).
STD NMR titration experiments for mimic 3 (concentrations 0.2,
0.5, 1, 2, 4 mM) were performed at 800 MHz and 25 ◦C in the
presence of 19 mM of DC-SIGN ECD. The KD, obtained as an
average of different selected ligand protons, was 0.4 (± 0.1) mM,
(Fig. 8).
Fig. 8 KD determination based on STDNMRusing the binding isotherm
of STD-AF0 initial growth rates approach.39
STD NMR competition experiments
Since it is known that the binding process of DC-SIGN to
fucose-containing LewisX carbohydrates and to high mannose
glycans, (Man)9(GlcNAc)2, is based on speciﬁc interactions,36,40
we wanted to analyse the competition between LewisX(OMe), a-
Man(OCH2CH2N3), and mimic 4, by STD NMR. The solid state
data strongly suggest that the recognition site is the same in all
cases. Thus, a decrease on the STD magnitude upon addition of
the second ligand would conﬁrm the competition for the same
binding site.
First, we measured the competition of mannose derivative with
mimic 4 (Fig. 9, a), as well as with LewisX(OMe) (Fig. 9, b). In
both cases there was a decrease in STD intensity after addition
of 1 mM of a-Man(OCH2CH2N3), showing that mannose was
capable of displacing both, mimic 4 and LewisX (1) and, therefore,
the three ligands compete for the same binding site, corroborating
that we are detecting their speciﬁc interactions with DC-SIGN, by
STD NMR.
Concerning the competition experiment between LewisX(OMe)
and mimic 4, the results conﬁrmed, as expected, a competition
for the same site of interaction, and evidenced a higher relative
afﬁnity ofmimic 4 in comparison to the natural ligand. Indeed, the
STD growth curves belonging to LewisX(OMe) protons showed a
greater decreasewhen competingwithmimic 4 than in competition
withmannose derivative (Fig. 9, b). Thus, it can be concluded from
this experiment that 4 is a stronger DC-SIGN binder than LewisX
or mannose.
Finally,we carried out competition experiments betweenmimics
3 and 4. To that aim,we prepared a sample containing both ligands
at the same concentration, in the presence of 19 mM of DC-SIGN
(ECD). As we could differentiate some of the signals of protons
belonging to each mimic, we were able to integrate the intensities
Fig. 9 STDNMR competition experiments. STD growth curves of a) the
protonH-1 of fucose of 4 (squares), in the presence ofmannose (circles), or
LewisX(OMe) 1 (triangles); b) the proton H-Ac of N-acetyl-glucosamine
of 1 (triangles), in the presence of mannose (circles), or 4 (stars).
of STD signals for each proton independently. The corresponding
STD growth curves obtained for the two mimics were comparable
and, in consequence, DC-SIGN should have the same afﬁnity for
both ligands within experimental error (Fig. 10). These results are
in agreement with SPR inhibition data.10
Fig. 10 STD NMR competition experiments between 3 and 4. STD
growth curves belonging to H-1 of fucose in mimic 3 (squares) and mimic
4 (circles).
This journal is © The Royal Society of Chemistry 2011 Org. Biomol. Chem., 2011, 9, 7705–7712 | 7709
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Conclusions
We have studied the binding of two fucose-containing mimics 3
and 4 and LewisX 1 to DC-SIGN (ECD) by NMR and molecular
modelling. In all cases, NMR reveals that, despite their ﬂexibility,
there are little or no signiﬁcant structural changes on the ligand
upon binding in terms of change of conformation. Remarkably,
these LewisX and fucosyl glycomimetics 3 and 4 are recognised by
DC-SIGN using the same binding site that recognises mannose
derivatives, as seen in previous NMR or X-ray studies. This is
sustained by STD competition experiments between mimic 4,
LewisX 1, and a-Man(OCH2CH2N3), which showed a decrease
in the STD signals when the second ligand was added. These
compounds have a global common shape that lead to a common
binding mode where the fucose interacts with Ca2+ using two
adjacent hydroxyl groups; glucosamine or cyclohexyl rings are
pointing towards the outside; and galactose or aromatic rings are
oriented back to the DC-SIGN binding site. These experiments
additionally concluded that the better binder in those experimental
conditions were bothmimics.We have interpreted this result as the
ability of the aromatic ring to replace the Gal moiety establishing
new interactions, which have been conﬁrmed in STD experiments
(Fig. 6 and 7).
This observation is of great interest for the design of new
DC-SIGN inhibitors as the substitution of the galactose ring by
the aromatic moiety simpliﬁes and shortens the synthesis of the
ligands without affecting the afﬁnity for the lectin. This has been
demonstrated by the determination of theKD value of 3which was
within the same range of the natural antigen LewisX.
The STD NMR quantitative analysis indicates that binding of
glycomimetics 3 and 4 is multimodal, and that several ligand
orientations can be recognised by the lectin, as we have previ-
ously demonstrated in the case of DC-SIGN (ECD) binding by
mannose-containing inhibitors.41 Furthermultimodal analysiswill
be considered in order to obtain a precise characterization of the
orientations of the ligands into the DC-SIGN binding pocket.
Experimental section
NMR spectroscopy
NMR spectroscopy experiments were performed on Bruker Digi-
tal Avance 800 MHz and DRX 500 MHz spectrometers equipped
with 5 mm inverse triple-resonance probes. NMR samples were
prepared in 500–600 mL of 99.9% D2O. For the experiments with
the receptor (DC-SIGN ECD 19 mM), the receptor was produced
as previously described,42 and concentrated at 19 mMafter dialysis
in buffer: D2O (150 mM NaCl, 4 mM CaCl2, 25 mM d-Tris, pD =
8). Different concentrations of ligands were used depending on the
experiments: 2 mM for complete assignment of the signals, 1 mM
for epitope mapping and competition experiments and 0.2, 0.4,
1.0, 2.0 and 4.0 mM (titration experiments) for KD determination.
Distances in Table 1 were calculated using the Tropp equation
when adequate.
STD NMR experiments were carried out at 10 and 25 ◦C by
using a train ofGaussian shaped pulses of 49ms andwith an inter-
pulse delay of 1 ms.43 Saturation times to obtain the STD buildup
curves were 0.5, 1, 1.5, 2, 3, 4 and 5 s. The on-resonance frequency
was set to -0.5 or -1 ppm, whereas off-resonance frequency was
40 ppm. Blank experiments were performed to assure the absence
of direct saturation to the ligand protons.
NOESY experiments were performed with a relaxation delay of
1.5 s, using a phase sensitive pulse program with gradient pulses
in mixing time and with presaturation.44,45
To determine KD the binding isotherms were constructed from
initial slopes of STD ampliﬁcation factors (STD-AF0) calculated
at every ligand concentration along the titration. The value of
STD-AF0 was obtained by ﬁtting the STD-AF evolution with the
saturation time to the equation
STD-AF(t) = a(1 - exp(-bt))38
as the product of the coefﬁcients ab. The STD-AF0 values were
then plotted as a function of the concentration of ligand, and the
resulting isotherm of initial slopes was mathematically ﬁtted to a
Langmuir equation to obtain the dissociation constant.46
Computational methods
All calculations were run using the Schro¨dinger suite of programs
through the Maestro 9.0 graphical interface.47 Conformational
search was performed by using the MacroModel/Batchmin24
package and the AMBER* force ﬁeld19,20 (Kolb’s parameters were
used for the hydroxy acid moiety)48 and MM3* force ﬁeld21,22
by using 10 000 steps of the Monte Carlo Multiple Minimum
method (MCMM).16 Bulk water solvation was simulated by using
generalized Born GB/SA continuum solvent model.49 Truncated
Newton conjugate gradient (TNCG) procedure, extended cut-off
distances (equivalent to a van der Waals cut-off of 8.0 A˚, an
electrostatic cut-off of 20.0 A˚ and a H-bond cut-off of 4.0 A˚),
were used.
The MC/SD17 dynamic simulations, were run with AMBER*,
MM3* and OPLS_2005 force ﬁelds.18,23 All simulations were
performed at 300 K, with a dynamic time step of 1–1.5 fs and a
ratio of SD to MC of 1. Convergence was checked by monitoring
both energetic and geometrical parameters.
Protein setup: Starting from the X-ray crystal structure (reso-
lution = 1.80 A˚) of human DC-SIGN complex, (pdb entry 1SL5;
complex of DC-SIGN CRD and lacto-N-fucopentaose III (Fuca
1,3-(Galb 1,4)-GlcNAc 1,3-Galb) (LNFPIII), a molecular model
of the protein was prepared. The crystal structure of 1SL5 (pdb
structure) was modiﬁed by removing all the waters of crystal-
lization except W13 and W36,28,30,50 hydrogens were added using
Maestro.47 The preparation of the protein was performed using
the methodology previously described by Bernardi’s group.28 The
complex structure coming from the 1SL5 pdb entrywasminimized
with the OPLS-2005 force ﬁeld and using the convergence method
TruncatedNewton Conjugate Gradients, with coordinates of Ca2+
atom and the oxygens of the water 13 and 36 in the binding site
ﬁxed to their crystallographic positions.
Docking
The previous structure was employed as receptor in the docking
studies in the Grid generation and as reference structure. An
“enclosing box” with dimensions of 36 A˚ and a partial charge
cut off of 0.25 were set. No constraints were established to allow
the ligand to explore freely the bounding box.
7710 | Org. Biomol. Chem., 2011, 9, 7705–7712 This journal is © The Royal Society of Chemistry 2011
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Then for the ligand docking we deﬁned the core pattern
comparison with the heavy atoms of fucose and the hydroxyls
coordinating the calcium ion, based on experimental data.51 A
tolerance of 3.5 A˚ was set, in order to ensure the maximum
conformational freedom of the fucose moiety while preserving
the interaction fucose-Ca2+ and to allow different binding modes
involving the hydroxyl groups O2–O3 or O3–O4.
Starting from the same minimized complex and using the
previous Grid ﬁle, further structural models for the interaction
of the mimic 3 (global minimum) with DC-SIGN were generated
by QM-Polarized docking protocol of Glide.34 This protocol aims
to improve the partial charges on the ligand atoms in a Glide
docking runby replacing themwith charges derived fromquantum
mechanical calculations on the ligand in the ﬁeld of the receptor.
CORCEMA-ST
The three-dimensional structures employed for the full relaxation
matrix calculations were based on the crystallographic structure
of the complex of human DC-SIGN with LewisX (pdb 1SL5)
and prepared as already discussed. For each structure, hydrogen
atoms were added and energy minimization was applied using
Maestro 9.0.47 All exchangeable hydrogen atoms were excluded in
the calculations, as the STD NMR experiments were performed
in D2O. Assuming a spherical shape for the protein tetramer,
the correlation time of bound ligand was set to 144 ns whereas
we chose a value of 0.5 ns for the free ligand correlation time
and a value of 10 ps for the methyl group internal correlation
time. To reduce the dimensions of the matrices, a cut off of
8 A˚ from the ligand was used. The STD intensities for each
binding mode were calculated as percentage fractional intensity
changes (Scalc,k = (([(I0k - I(t)k)100]/I0k), were k is a particular
proton in the complex, and I0k its thermal equilibrium value)
from the intensity matrix I(t),14 and the calculation was carried
out for the set of saturation times experimentally measured (0.5,
1, 1.5, 2, 3, 4 and 5 s). From the resulting STD build-up curves, a
mathematical ﬁtting to a monoexponential equation (STD(tsat) =
STDmax(1 - exp(-ksattsat)))38 was done, and the initial slope STD0calc
was obtained. The theoretical STD values were compared to
experimental ones using the NOE R-factor35,52 deﬁned as:
S
S
W STD STD )
W (STD
0,k
exp
0,k
calc 2
k 0.k
exp
k (
)
−
2
(2)
In the eqn (2) STDexp0,k and STD
calc
0,k refer to experimental and
calculated initial slopes STD0 for proton k.
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